Sean Goldfaden is the Founder and CEO of CoEfficient Labs, a company specializing in helping the world's fastest-growing startups scale paid acquisition through various platforms such as LinkedIn Ads, Facebook & Instagram Ads, Google / Bing Ads, as well as non-traditional ads like TikTok Ads, Reddit Ads, Twitter Ads, and Pinterest Ads.

CoEfficient Labs focuses on scaling paid acquisition, with a particular emphasis on seed-to-Series D stages and excels in demand generation and conversion rate optimization for typical monthly budgets ranging from $10,000 to $250,000 and beyond. Their expertise lies in Shopify and e-commerce, with a sweet spot in scaling revenues from $30,000 to $250,000 per month.

The company operates uniquely by working in a Pod Formation, comprising three key roles: The Growth Lead, responsible for day-to-day ad operations and experiments; The Creative Lead, overseeing weekly creative sprints; and The Data Science Lead, managing weekly executive reports, tracking, and analytics.

Sean Goldfaden's professional journey includes roles such as Growth / Digital Marketing at Creative Circle, Growth / Social Media at Twenty20 Inc., CEO - Founder at Playfarer LLC, Social Media Manager at 1-800-DENTIST, Advertising Sales Intern at ABC Television, and Senior Sales Advisor at Vector Marketing.

Sean has a diverse educational background, having studied Communications and Sociology at Regents College in London, General Assembly courses, and earning a B.A. in Communications with a focus on Advertising and Psychology from the University of Miami.

CoEfficient Labs has gained trust from numerous Venture Capital firms, including A16Z, Upfront Ventures, Crosscut Ventures, M13, and SignalFire, for their expertise in scaling paid acquisition for startups.

If you're looking to scale your startup's paid acquisition or need assistance with demand generation and conversion rate optimization, CoEfficient Labs under Sean Goldfaden's leadership could be the solution you're seeking. Reach out to them for a free audit and non-binding trial via their website.